Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway.

Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway.

Item
http://www.wikidata.org/entity/Q43975528
Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor SymptomsMelatonin combats molecular terrorism at the mitochondrial level.Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation.Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?Pharmacological doses of melatonin induce alterations in mitochondrial mass and potential, bcl-2 levels and K+ currents in UVB-exposed U937 cells.MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1.Melatonin protects SK-N-SH neuroblastoma cells from amphetamine-induced neurotoxicity.Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin.Inhibition of platelet aggregation by 1-methyl-4-phenyl pyridinium ion (MPP+) through ATP depletion: Evidence for the reduced platelet activities in Parkinson's disease.Melatonin inhibits manganese-induced motor dysfunction and neuronal loss in mice: involvement of oxidative stress and dopaminergic neurodegeneration.Influence of hydroxyethyl starch on healing of colonic anastomosis in a rat model of peritonitis.Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions.Melatonin prevents the dynamin-related protein 1-dependent mitochondrial fission and oxidative insult in the cortical neurons after 1-methyl-4-phenylpyridinium treatment.Melatonin synergizes with low doses of L-DOPA to improve dendritic spine density in the mouse striatum in experimental Parkinsonism.
P2860

Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway.

Item
http://www.wikidata.org/entity/Q43975528
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Melatonin attenuates MPP+-indu ...... striatal dopaminergic pathway.
@en
Melatonin attenuates MPP+-indu ...... striatal dopaminergic pathway.
@nl
type
label
Melatonin attenuates MPP+-indu ...... striatal dopaminergic pathway.
@en
Melatonin attenuates MPP+-indu ...... striatal dopaminergic pathway.
@nl
prefLabel
Melatonin attenuates MPP+-indu ...... striatal dopaminergic pathway.
@en
Melatonin attenuates MPP+-indu ...... striatal dopaminergic pathway.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Melatonin attenuates MPP+-indu ...... striatal dopaminergic pathway.
@en
P2093
P2860
P304
P31
P356
10.1034/J.1600-079X.2002.01871.X
P433
P478
P577
P698
P921